AURINIA PHARMACEUTICALS INC (AUPH) Stock Cash Flow
NASDAQ:AUPH - Nasdaq - CA05156V1022 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 39.84M | 5.75M | -78.02M | -108.18M | -180.97M | |||
| Depreciation Amortization | 19.45M | 19.45M | 11.65M | 2.71M | 2.76M | |||
| Change In Working Capital | -8.76M | 5.45M | -5.61M | -6.82M | -21.63M | |||
| Taxes Paid | -1.94M | -2.18M | 496.00K | -1.98M | -260.00K | |||
| Other non cash items | 13.75M | 13.74M | 38.52M | 32.76M | 42.15M | |||
| OPERATING CASH FLOW | 64.29M | 44.39M | -33.46M | -79.53M | -157.69M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -286.00K | -281.00K | -718.00K | -290.00K | -1.50M | |||
| Other Investing Activity | 21.35M | 39.54M | -5.99M | -60.34M | -102.37M | |||
| INVESTING CASH FLOW | 21.06M | 39.26M | -6.71M | -60.63M | -103.87M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -11.98M | -11.99M | -10.03M | N/A | N/A | |||
| Stock Issued/Repurchased | -71.40M | -37.10M | 4.89M | 2.43M | 221.11M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | -83.38M | -49.09M | -5.13M | 2.43M | 221.11M | |||
| Exchange Rate Effect | N/A | N/A | N/A | N/A | N/A | |||
| CHANGE IN CASH | 1.97M | 34.56M | -45.30M | -137.73M | -40.45M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 64.29M | 44.39M | -33.46M | -79.53M | -157.69M | |||
| Capital Expenditure | -286.00K | -281.00K | -718.00K | -290.00K | -1.50M | |||
| FREE CASH FLOW | 64.00M | 44.11M | -34.18M | -79.82M | -159.19M | |||
All data in USD